These findings should not be used as an excuse not to optimize renin–angiotensin system inhibition and target urinary protein in patients with proteinuric nephropathies. Figure 1: Rate of GFR ...

Given the few therapeutic options available for proteinuric nephropathies and the antiproteinuric effects of endothelin-receptor antagonists when given at low doses, future nephrology research may ...

Medication errors frequently occur in the treatment of patients with renal insufficiency and can cause serious adverse events. Although computerized systems that adjust the drug dose on the basis ...